Element Biosciences

Element Biosciences is a biotechnology startup founded in 2017 with the slogan of "Opening the world of biology to new possibilities." The company aims to democratize access to advanced biological tools and drive impactful discoveries to benefit humanity. Element Biosciences focuses on developing disruptive DNA sequencing and multiomics technology for research markets. The company's approach involves innovating every fundamental element of a biological assay system to empower customers with affordable, high-quality data and an improved user experience, ultimately accelerating scientific discoveries. In its latest funding round, Element Biosciences secured a significant $276.00M Series C investment on 29 June 2021. The funding was backed by a notable consortium of investors including RA Capital Management, Venrock, Meritech Capital Partners, T. Rowe Price, Fidelity, Foresite Capital, Janus Handerson, Logos Capital, JS Capital Management, and Counterpoint Global. The company's geographical headquarters is located in the United States. With a focus on advancing biological technologies and facilitating groundbreaking discoveries, Element Biosciences has positioned itself at the forefront of innovation in the biotechnology industry.